SCHEMBL2329310

SCHEMBL2329310

CC(c1ccc(C(=O)c2ccccc2)cc1)[Bi](C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
SRD5A2 P31213 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
HPGD P15428 4/20 0.49
PTGS1 P23219 3/20 0.49
PTGS2 P35354 3/20 0.49
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
CXCR1 P25024 2/20 0.49
CXCR2 P25025 2/20 0.49
ELANE P08246 2/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RECQL P46063 1/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49
PMP22 Q01453 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50522 0.80 ALDH1A1 (0.61) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL10022962 0.80 ALDH1A1 (0.61) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL28587552 0.79 ALDH1A1 (0.58) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL2333423 0.79 MAPT (0.43) ALDH1A1SMN1; SMN2HPGDRAB9AMAPT
SCHEMBL2333288 0.78 MAPT (0.49) ALDH1A1SMN1; SMN2MAPTELANEMEN1
SCHEMBL2329699 0.77 TAAR1 (0.42) ALDH1A1LMNAKDM4EHIF1A
SCHEMBL7704968 0.77 PTGS2 (0.71) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL21276570 0.77 ALDH1A1 (0.56) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL11141744 0.77 ALDH1A1 (0.56) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1
SCHEMBL677887 0.77 ALDH1A1 (0.56) ALDH1A1SRD5A2SMN1; SMN2HPGDPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2133357-B1 LIVING RADICAL POLYMERIZATION PROMOTER OTSUKA CHEMICAL CO LTD (JP) 2016-11-16 EP disclosed
US-8076430-B2 Living radical polymerization promoter OTSUKA CHEMICAL CO., LTD. (JP) 2011-12-13 US disclosed
EP-1829883-B1 ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER OTSUKA CHEMICAL CO LTD (JP) 2011-08-17 EP disclosed
US-7847043-B2 Organic bismuth compound, method for producing same, living radical polymerization initiator, method for producing polymer using same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2010-12-07 US disclosed
US-20100022728-A1 LIVING RADICAL POLYMERIZATION PROMOTER OTSUKA CHEMICAL CO., LTD. (JP) 2010-01-28 US disclosed
EP-2133357-A1 LIVING RADICAL POLYMERIZATION PROMOTER Otsuka Chemical Holdings Co., Ltd. (JP) 2009-12-16 EP disclosed
US-20070265404-A1 Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer OTSUKA CHEMICAL CO., LTD. (JP) 2007-11-15 US disclosed
EP-1829883-A1 ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER Otsuka Chemical Co., Ltd. (JP) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265404-A1 Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer DOHH, COASY, ODC1 ALDH1A1 874/4885SRD5A2 1013/4885SMN1; SMN2 3616/4885
US-20100022728-A1 LIVING RADICAL POLYMERIZATION PROMOTER DNMT1, CYP1B1, DNMT3B ALDH1A1 321/4885SRD5A2 1230/4885SMN1; SMN2 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.